An OA phenotype may obtain major benefit from bone-acting agents

J.A. Roman-Blas, S. Castaneda, R. Largo, W.F. Lems, G. Herrero-Beaumont

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	421-428
Journal	Seminars in Arthritis and Rheumatism
Volume	43
Issue number	4
DOIs	https://doi.org/10.1016/j.semarthrit.2013.07.012
Publication status	Published - 2014

Cite this

@article{1ce34c57cf844eaa8383392cd82cbbb6,

title = "An OA phenotype may obtain major benefit from bone-acting agents",

author = "J.A. Roman-Blas and S. Castaneda and R. Largo and W.F. Lems and G. Herrero-Beaumont",

year = "2014",

doi = "10.1016/j.semarthrit.2013.07.012",

language = "Undefined/Unknown",

volume = "43",

pages = "421--428",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - An OA phenotype may obtain major benefit from bone-acting agents

AU - Roman-Blas, J.A.

AU - Castaneda, S.

AU - Largo, R.

AU - Lems, W.F.

AU - Herrero-Beaumont, G.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.semarthrit.2013.07.012

DO - 10.1016/j.semarthrit.2013.07.012

M3 - Article

C2 - 24016748

VL - 43

SP - 421

EP - 428

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 4

ER -